Amicus Therapeutics, Inc.
Symbole: FOLD
NASDAQ
9.48
USDPrix du marché aujourd'hui
-18.3613
Ratio P/E
-0.1932
Ratio PEG
2.81B
Cap MRK
- 0.00%
Rendement DIV
Amicus Therapeutics, Inc. Structure de gestion
Informations sur la direction
Nom de l'entreprise | Titre de l'entreprise |
---|---|
Dr. Jill Weimer Ph.D. | Chief Science Officer |
Mr. Patrik S. Florencio Esq. | Global Chief Compliance & Risk Officer |
Dr. Jeffrey P. Castelli Ph.D. | Chief Development Officer |
Ms. Diana Moore | Head of Global Corporate Communications |
Ms. Ellen S. Rosenberg | Chief Legal Officer & Corporate Secretary |
Mr. Simon Nicolas Reade Harford | Chief Financial Officer |
Mr. David M. Clark | Chief People Officer |
Andrew Faughnan | Senior Director of Investor Relations |
Ms. Samantha Prout | Chief Accounting Officer & Controller |
Mr. Bradley L. Campbell M.B.A. | Chief Executive Officer, President & Director |
Actions similaires
Vous pouvez également être intéressé par :MRVI
Direction générale :
- Ms. Debra Hart
- Ms. Rebecca Buzzeo
- Dr. Kate E. Brode...
CMRA
Direction générale :
- Ms. Janice Marie ...
- Dr. David Soane ...
- Mr. Michael G. Ca...
GUBRA.CO
Direction générale :
- Ms. Trine Nygaard...
- Mr. Kristoffer R...
- Ms. Margit Bloch ...
T5O.DE
Direction générale :
- Dr. Mark-André F...
- Dr. Dirk Kaiser
- Dr. Bruno Rosen
6826.HK
Direction générale :
- Ms. Caixia Ren
- Mr. Ming King Ch...
- Ms. Min Tian
PPBT
Direction générale :
- Mr. Ido Morpurgo...
- Mr. Lior Fhima C...
- Dr. Michael Schi...
SPHRF
Direction générale :
- Ms. Cheryl Maley...
- Mr. Justin Cahill